| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |